Primary myelofibrosis (PMF)
Clinical trials for Primary myelofibrosis (PMF) explained in plain language.
Never miss a new study
Get alerted when new Primary myelofibrosis (PMF) trials appear
Sign up with your email to follow new studies for Primary myelofibrosis (PMF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill combo aims to tame bone marrow cancer
Disease control OngoingThis early-phase study tests whether adding a new drug called pelabresib to the standard treatment ruxolitinib is safe and helpful for Japanese adults with myelofibrosis, a type of bone marrow cancer. Only 6 people will take part, and the main goal is to check for side effects an…
Matched conditions: PRIMARY MYELOFIBROSIS (PMF)
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Momelotinib access expanded for myelofibrosis patients in Long-Term safety study
Disease control OngoingThis study provides extended access to the drug momelotinib for 237 people with a type of bone marrow cancer called myelofibrosis. Participants had already been taking momelotinib in earlier studies and had not seen their disease get worse. The goal is to see how safe the drug is…
Matched conditions: PRIMARY MYELOFIBROSIS (PMF)
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC